Drug Shortage Report for APO-RIZATRIPTAN RPD

Last updated on 2020-07-06 History
Report ID 490
Drug Identification Number 02393492
Brand name APO-RIZATRIPTAN RPD
Common or Proper name RIZATRIPTAN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date 2020-07-03
Actual end date 2019-04-05
Shortage status Resolved
Updated date 2020-07-06
Company comments Product was discontinued
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-07-06 French Compare
v14 2020-07-06 English Compare
v13 2020-05-12 French Compare
v12 2020-05-12 English Compare
v11 2020-03-30 French Compare
v10 2020-03-30 English Compare
v9 2020-03-30 French Compare
v8 2020-03-30 English Compare
v7 2018-01-10 French Compare
v6 2018-01-10 English Compare
v5 2017-12-14 French Compare
v4 2017-12-14 English Compare
v3 2017-03-11 French Compare
v2 2017-03-11 French Compare
v1 2017-03-11 English Compare

Showing 1 to 15 of 15